Saturday 17 October 2026
Export GCTK’s income statement to Excel — free account
GlucoTrack, Inc.
GCTK Healthcare Medical Instruments & Supplies
In the quarter to June 2026, EPS grew 92.1%, free cash flow grew 3.42% and total debt rose 777.8%, each against the same quarter a year earlier.
0.73
0.10
−12.05%
Follow GCTK
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 2 | 1 | 3 | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Altman Z-Score |
757,570.46 | 483,614.12 | 827,344.05 | 26,019,048.63 | — | — | — | — | — | — |
P/S ratio |
27,686,110.20 | 24,952,324.40 | 9,303,494.32 | 522,885,375.00 | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(64.35) | (145.73) | (505.41) | (301.18) | — | — | — | — | — | — |
P/Operating CF |
(17,537,881.93) | (18,663,578.68) | (4,507,473.85) | (136,547,593.22) | — | — | — | — | — | — |
Beneish M-Score |
0.36 | (15.03) | (14.97) | 2.40 | — | — | — | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
EV/Sales |
27,686,110.27 | 24,952,324.66 | 9,303,494.51 | 522,885,374.04 | — | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
EV/Operating CF |
(3,187,775.34) | (2,494,809.19) | (1,004,076.83) | (27,894,372.35) | — | — | — | — | — | — |
EV/FCF |
(3,142,517.13) | (2,486,583.85) | (1,002,969.78) | (27,730,789.85) | — | — | — | — | — | — |
Quick Ratio |
0.10 | 0.05 | 0.04 | 0.22 | 7.35 | 6.87 | 2.28 | 2.97 | 4.41 | 1.55 |
Current Ratio |
0.86 | 0.33 | 0.10 | 0.32 | 7.61 | 6.91 | 2.35 | 3.22 | 4.52 | 1.61 |
Net Debt/EBITDA |
0.00 | (0.01) | (0.01) | 0.02 | 3.09 | 1.46 | 0.48 | 0.61 | 0.37 | 0.25 |
Debt/Assets |
6.58% | 10.95% | 24.44% | 30.38% | 2.65% | 3.72% | 8.00% | 4.00% | 3.51% | 43.54% |
Debt/Equity |
(0.01) | (0.01) | (0.06) | (0.24) | 0.03 | 0.05 | 0.16 | 0.06 | (0.02) | 1.21 |
Asset Turnover |
0.27 | 0.29 | 0.04 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.98 | 0.57 | 0.73 | 1.11 | 1.30 | 0.93 | 0.84 | 0.92 | 0.55 | 0.79 |
Capex/Depreciation |
(1.28) | (0.29) | (0.09) | (0.45) | (1.13) | (0.02) | 0.04 | 0.00 | (2.89) | (0.43) |
| 60.38% | 75.05% | 69.06% | 164.10% | (71.23%) | (57.54%) | (138.92%) | (320.62%) | 461.02% | 381.20% | |
| (235.53%) | (500.21%) | (569.80%) | (394.13%) | (46.08%) | (48.21%) | (101.92%) | (193.30%) | (417.03%) | (281.60%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
5,997.45% | 460.68% | 243.51% | 247.61% | (29.85%) | (76.87%) | (315.43%) | (209.78%) | (492.52%) | (639.45%) |
Average Days of Receivables |
54.96 | 75.41 | 191.31 | 122.84 | 0.00 | — | — | — | — | — |
Research and Development Expense of Revenue |
471.11% | 544.11% | 6,972.18% | 772.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
553.49% | 1,349.92% | 8,159.08% | 1,013.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
11.48% | 458.90% | 1,621.15% | 171.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Graham Number |
6.31 | 9.88 | 2.48 | 0.07 | — | — | — | — | — | — |
Earnings Yield |
0.00% | 0.00% | 0.00% | 0.00% | — | — | — | — | — | — |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | — | — | — | — | — | — |
Revenue per Share |
0.11 | 0.09 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.92) | (0.94) | (0.58) | (0.03) | (17,505.00) | (18,845.00) | (18,645.00) | (32,790.00) | (31,225.00) | (368.12) |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | (265.00) | (5.00) | 5.00 | 0.00 | (260.00) | (2.32) |
Free Cash Flow per Share |
(0.93) | (0.94) | (0.58) | (0.03) | (17,770.00) | (18,850.00) | (18,640.00) | (32,790.00) | (31,485.00) | (370.43) |
Cash per Share |
0.03 | 0.01 | 0.01 | 0.00 | 49,115.00 | 30,310.00 | 11,560.00 | 22,460.00 | 14,042.50 | 178.33 |
Shareholders Equity per Share |
(1.89) | (2.64) | (0.34) | (0.01) | 44,910.00 | 25,775.00 | 6,150.00 | 15,985.00 | (32,500.00) | 68.31 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(1.89) | (2.64) | (0.34) | (0.01) | 44,910.00 | 25,775.00 | 6,150.00 | 15,985.00 | (32,500.00) | 68.31 |
Free Cash Flow |
(5.39) | (5.91) | (4.90) | (3.92) | (3.55) | (3.77) | (3.73) | (6.56) | (12.59) | (15.34) |
Working Capital |
(0.33) | (2.46) | (2.91) | (1.55) | 8.88 | 5.22 | 1.37 | 3.36 | 4.49 | 2.89 |
Capital Expenditures |
(0.08) | (0.02) | (0.01) | (0.02) | (0.05) | 0.00 | 0.00 | — | (0.10) | (0.10) |
Net Current Asset Value |
(11.39) | (17.02) | (3.25) | (1.79) | 8.61 | 5.00 | 1.17 | 3.16 | (13.16) | 2.66 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Capex to Sales |
0.13 | 0.03 | 0.12 | 0.11 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.25 | 0.31 | 0.39 | 0.38 | 0.32 | 0.61 | 0.58 | 0.48 | 0.38 | 1.62 |
Cash ROIC |
50.65% | 36.20% | 187.80% | 594.24% | (18.62%) | (32.93%) | (99.76%) | (83.17%) | 175.53% | (112.57%) |
Accounts Receivable Turnover |
11.07 | 5.51 | 0.60 | 4.48 | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
0.06 | 0.11 | 0.07 | 0.05 | 0.07 | — | — | — | — | — |
Average Payables |
1.36 | 2.03 | 2.24 | 1.80 | 1.20 | 0.75 | 0.65 | 0.76 | 0.92 | 1.15 |
Average Inventory |
1.12 | 1.19 | 0.56 | 0.18 | 0.23 | 0.14 | — | — | — | — |
Average Assets |
2.30 | 2.06 | 1.18 | 0.89 | 5.85 | 8.44 | 4.35 | 3.67 | 5.42 | 6.89 |
Average Common Equity |
(8.96) | (13.76) | (9.72) | (2.14) | 3.79 | 7.07 | 3.19 | 2.21 | (4.90) | (5.09) |
Columns are period end dates